Chapter 9. Alkylating Agents

  1. Sotiris Missailidis
  1. Ana Paula Francisco,
  2. Maria de Jesus Perry,
  3. Rui Moreira and
  4. Eduarda Mendes

Published Online: 7 NOV 2008

DOI: 10.1002/9780470697047.ch9

Anticancer Therapeutics

Anticancer Therapeutics

How to Cite

Francisco, A. P., Perry, M. d. J., Moreira, R. and Mendes, E. (2008) Alkylating Agents, in Anticancer Therapeutics (ed S. Missailidis), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470697047.ch9

Editor Information

  1. Department of Chemistry and Analytical Sciences, The Open University, Milton Keynes, UK

Author Information

  1. CECF, Faculty of Pharmacy, University of Lisbon, Lisboa, Portugal

Publication History

  1. Published Online: 7 NOV 2008
  2. Published Print: 21 NOV 2008

ISBN Information

Print ISBN: 9780470723036

Online ISBN: 9780470697047

SEARCH

Keywords:

  • alkylating agents - oldest anticancer drug class;
  • nitrogen mustards;
  • B-cell chronic lymphocytic leukaemia (B-CLL) and alkylating agents;
  • methylhydrazine derivatives;
  • procarbazine - monoamine oxidase (MAO) inhibitor;
  • nitrosoureas;
  • Novels nitrosourea derivatives

Summary

This chapter contains sections titled:

  • Introduction

  • Nitrogen Mustards

  • Methylmelamines and Ethylenimines

  • Methylhydrazine Derivatives

  • Alkylsulfonates

  • Nitrosoureas

  • Triazenes

  • References